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The prevalence of allergic and autoimmune diseases is increasing in developed countries, possibly due to reduced exposure to
microorganisms in childhood (hygiene hypothesis). Epidemiological and experimental evidence in support of this hypothesis is
accumulating. In this context, parasitic helminths are now important candidates for antiallergic/anti-inﬂammatory agents. Here
we summarize antiallergic/anti-inﬂammatory eﬀects of helminths together along with our own study of the eﬀects of Schistosoma
mansoni on Th17-dependent experimental arthritis. We also discuss possible mechanisms of helminth-induced suppression
according to the recent advances of immunology.
1.Introduction:Autoimmunity,Allergy,and
Helminth Infection
In 1989, the “hygiene hypothesis” was proposed by D.P.
Strachan in an article that claimed an inverse relationship
between the occurrence of hay fever and numbers of
siblings [1]. According to the hypothesis, atopic disorders are
due to reduced exposure to microorganisms in childhood.
Nowadays, the concept is becoming more accepted with
accumulating evidence not only in atopic diseases but
also in autoimmune inﬂammatory diseases. For instance,
the incidence of multiple sclerosis (MS) is higher in high
latitude countries (= westernized developed countries) than
in equatorial areas [2]. Not only residents of western
countries but also immigrants from developing countries
are at high risk of developing inﬂammatory bowel diseases
(IBDs) and asthma [3]. In the case of type 1 diabetes (T1D),
a similar geographical distribution to the diseases above and
aninversecorrelationtohygieneconditionsareobserved[4].
A population-based ecologic study in Canada showed that
IBD, including ulcerative colitis (UC) and Crohn’s disease
(CD), correlated with a high socioeconomic status, low rate
of enteric infection, and high rate of MS [5].
Many studies have demonstrated that helminth infec-
tions lower the risk of autoimmunity or allergy. For instance,
an inverse correlation between autoimmune liver diseases
and Strongyloides stercoralis infection was demonstrated in
Okinawa, Japan [6]. Cross-sectional studies on the rela-
tionship between skin prick tests and helminth infections
suggested a general protective eﬀect on the atopic reaction
[7]. The authors summarized eﬀects of geohelminths on
the risk of asthma according to previous studies; that is,
hookworm lowered but Ascaris increased the risk of asthma
and Trichuris had no eﬀect. Collectively, it is concluded that
at least some helminths seem to have anti-allergic or anti-
inﬂammatory eﬀects in humans.
Experimental studies have also shown protective eﬀects
of helminth infections in animal models of autoimmunity
(e.g., colitis, arthritis, and diabetes) and allergy (e.g., airway
hypersensitivity) [3,8–10].Inthisreview,wediscusspossible
mechanisms of anti-allergic/anti-inﬂammatory eﬀects of
helminthsinanimalmodelsincludingautoimmunearthritis.
Possible clinical applications and future prospects are also
discussed.
2. Helper T Cell Subset Dependence of
ExperimentalImmunological Disorders
Based on T cell skewing patterns and their relative impor-
tance in the pathogenesis, disorders with excessive immune2 Journal of Biomedicine and Biotechnology
responses had been brieﬂy classiﬁed as “Th1 diseases”
and “Th2 diseases” according to the Th1/Th2 paradigm.
However, the recent discovery of a novel pathogenic T cell
subset (Th17) [11] led investigators to the concept of “Th17
disease.”Whilemostatopicimmunedisorders(e.g.,hayfever
and bronchial asthma) can be classiﬁed as Th2 diseases, the
classiﬁcation of autoimmune diseases is relatively diﬃcult.
Experimental autoimmune encephalomyelitis (EAE) as a
model of MS was long thought to be a Th1 disease; however,
the recent studies using IL-12/23 subunit (p35, p19, or p40)
deﬁcient mice revealed the progression of the disease to
be dependent on the IL-23/IL-17 axis (= Th17 response)
rather than IL-12/IFNγ axis (= Th1 response) [12]. The
pathogenic role of IL-17 was shown directly by the ﬁnding
that EAE development was signiﬁcantly suppressed in IL-
17-deﬁcient mice [13]. The importance of the IL-23/IL-
17 axis is supported also in human MS [12]. Regarding
T1D, the diabetes observed in NOD mice (a model of T1D)
has been classiﬁed as a Th1 disease despite the presence
of some controversial study results [14–16]. Recent reports
demonstrated that Th17 cells could also cause diabetes, but
only after their conversion to Th1-type cells [17, 18]. This
means that there is unknown plasticity of helper T subsets.
Regarding IBD, the pathogenic roles of both Th1 and Th17
responses in TNBS-induced colitis (a model of IBD) are
still controversial [19–23]. Collectively, some experimental
autoimmune disorders cannot yet be distinctly classiﬁed as
either Th1 or Th17 disease.
3.ProtectiveEffectsofHelminthsagainst
Immunological Disorders
The eﬀects of schistosomes and other helminths on exper-
imental autoimmunity/allergy are summarized in Table 1.
Surprisingly, helminths have been shown to suppress all
types (Th1, Th2, and Th17) of disease in the models
described above [24–45]. Considering classical Th1/Th2
paradigm, it is reasonable to speculate that helminth-
induced Th2-skewing with downregulation of Th1 immune
responses results in an amelioration of Th1 diseases. As
IL-4 is known to suppress Th17 development [46], Th17
response could also be suppressed as well as Th1 response
in helminth-infected or helminth antigen-treated animals.
In fact, STAT6-dependent IL-4/IL-13 signaling was shown to
be essential in the suppression of TNBS-induced colitis [29]
and EAE [25] by schistosome eggs, although the authors did
not measure changes of IL-17. Given that the involvement
of Th1 and Th17 in some forms of autoimmunity is still
controversial, downregulation of both T helper responses
may be beneﬁcial for the amelioration of various kinds of
autoimmunity. Along with other investigators, we recently
found that schistosome-infected mice became resistant to
experimental arthritis accompanying down-regulation of
both Th1 and Th17 responses of splenocytes [47]. Likewise,
Ruyssers et al. reported suppression of TNBS-induced coli-
tis by schistosome antigens, accompanying down-regulation
of IL-17 gene expression in the colon and mesenteric lymph
node (MLN) [28]. An intestinal nematode (Heligmosomoides
polygyrus) infection was also reported to suppress IL-17
production in MLN cells and lamina propria mononuclear
cells [48]. The authors showed that the blocking of both IL-4
and IL-10 restored IL-17 production in vitro. Another study
revealed that Fasciola hepatica-induced down-regulation of
autoantigen-speciﬁc Th1 and Th17 responses (and protec-
tion from EAE) was dependent on TGF-β,n o tI L - 1 0[ 49].
Although the mechanisms of Th17’s down-regulation by
helminths are not yet established, some of the mechanisms
might be common to those of Th1’s down-regulation (e.g.,
through induction of IL-4 and IL-10, down-regulation of IL-
12p40) and others might be distinct.
In our study on experimental arthritis in mice [47], we
found no increase of Treg-related gene expression (Foxp3,
TGF-β and IL-10) in the paws of S. mansoni-infected mice
comparedtothepawsofuninfectedcontrolmice.AsTregcell
population was known to expand in schistosome-infected or
egg-treated mice [31, 32, 35, 50], the cells might participate
in the regulation of the disease systemically rather than
locally. To conﬁrm the essential involvement of Treg cells
in the antiarthritic eﬀects of schistosome, further studies
(e.g., persistent Treg depletion experiments) are necessary.
In contrast to our result, in the case of diabetes in NOD
mice, schistosome egg antigens induce inﬁltration of Treg
cells at a local inﬂamed site (pancreas) [32]. Likewise, ﬁlarial
nematode (Litomosoides sigmodontis) infection induced Treg
cells and protected mice from the diabetes [39]. H. polygyrus
also protected mice from the diabetes; however, the protec-
tion was not dependent on Treg cells [40]. In addition to
schistosome and nematodes, tapeworm (Taenia crassiceps)
infection also has anti-diabetic eﬀects in multiple low-dose
streptozotocin-induced diabetes (MLDS) in mice [45,i n
this issue]. In the study, alternatively activated macrophages
(AAMφ)increasedwhereasTregpopulationdidnotincrease.
Taken together, these studies suggest that there may be
various mechanisms in anti-diabetic eﬀects of helminths.
We also found that schistosome-induced down-
regulation of Th1 and Th17 occurred in the same period
after the infection, corresponding to the beginning of
egg-laying (unpublished observation). This result suggests
that egg deposition is the major stimulus to lower Th17
responses (as well as Th1 response) in murine experimental
schistosomiasis. Further studies using schsitosome eggs are
currently in progress in our laboratory.
Some epidemiological studies support that helminth
infections are protective against atopic reactions and/or
symptoms [51–53]. The helminth-induced suppression of
Th2 diseases (atopic disorders etc.) is diﬃcult to explain
in terms of the Th1/Th2 paradigm. In the paradigm,
theoretically, helminth infections are expected to cause
IgE overproduction and hypereosinophilia, followed by
exacerbation of allergic reactions. Indeed, persistent bron-
choalveolar eosinophilia, airway hyperresponsiveness [54],
and exacerbation of allergic airway inﬂammation [55]
were observed in Toxocara-infected mice. One interesting
explanationofanti-allergiceﬀectsofhelminths isintroduced
in a review by Fallon and Mangan [56], in which Th2
responses are subdivided to “allergic” and “modiﬁed”, with
helminth-induced Th2 responses corresponding to the latterJournal of Biomedicine and Biotechnology 3
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type characterized by predominant Treg and IL-10 responses
and a relatively weak IL-5 response. (The authors, however,
describe that such modiﬁcations are localized in the lungs
and diﬀerent from systemic responses.) Along with this
hypothesis, administration of Ascaris extract was shown
to inhibit not only IL-5 production but also eosinophilic
inﬂammation in a murine asthma model [42]. Filarial infec-
tion also suppressed airway hyperreactivity and pulmonary
eosinophiliainamurineasthmamodel[43].Thesuppressive
eﬀect of the ﬁlarial worms on hyperreactivity was dependent
on Treg cells and TGF-β. As helminths seem to have both
allergenicandimmunomodulatorycomponents[38]intheir
bodies, the balance of them may determine the outcomes
(i.e., exacerbation or amelioration) of allergic disorders.
Helminthic infections often result in expansion and/or
activationofTregcells[31,32,35,36,50].Bcellsarealsosug-
gested to be involved in disease suppression [34] through IL-
10. However, the importance of IL-10 in helminth-induced
suppression of atopic diseases is not fully established; that
is, mesenteric lymph node cells from Heligmosomoides-
infected IL-10-deﬁcient mice could confer protection against
allergic airway inﬂammation [36]. Likewise, in humans,
anti-allergic eﬀect of Ascaris lumbricoides is associated with
Treg, but not with IL-10 [57]. In the case of mice, IL-
35, a recently identiﬁed eﬀecter molecule of Treg cells
[58], might be involved in the suppression. Other than
the regulation of lymphocytes, helminth-derived products
have potential anti-allergic eﬀects on various kinds of cells.
For instance, the ﬁlarial product ES-62 was shown to
suppress the release of mediators from bone marrow-derived
mast cells [59]. In addition, helminths generally induce
AAMφ [60–63]. Such macrophages not only suppress the
pathogenesis by the parasites themselves [61] but also may
suppress pathological immune responses to autoantigens or
allergens. The involvement of AAMφ in anti-diabetic eﬀects
was suggested in experimental tapeworm infection [45].
On the other hand, schistosome-modulated macrophages
(but NOT AAMφ) were involved in suppression of dextran
sodium sulfate-(DSS-) induced colitis [64]. These studies
suggest the presence of various suppressive mechanisms by
helminths. Immune cells and mediators possibly involved in
the helminth-induced immunomodulation are illustrated in
Figure 1 .
4.ProtectiveEffectsofHelminthsagainst
ExperimentalAutoimmune Arthritis
Collagen-induced arthritis (CIA) is an autoimmune arthritis
in mice and rats [65] widely used as a model of rheumatoid
arthritis (RA). Although the role of the IL-12/IFNγ axis in
CIA has been controversial [66, 67], recent ﬁndings suggest
that IFNγ has ameliorating rather than exacerbating eﬀects
[68–71]. Instead, the IL-23/IL-17 axis was recently shown to
be important in the pathogenesis of CIA [71–76]a sw e l la s
RA in humans [77].
Regarding anti-arthritic eﬀects of helminths, a ﬁlarial
ES product ES-62 [78] and porcine roundworm Ascaris
suum extract [37] were shown to suppress CIA in mice. As
Helminths
ES products
IL-12/23 p40↓
Arginase1↑
Mφ/DC
B
NKT
Treg
Tr1
Basophil
TGF-β
IL-10
IL-4
TGF-β
IL-10
IL-4
IL-25?
IL-27?
IL-35?
Th1
Th17
Allergic
Th2 TGF-β
IL-10
Figure 1: Possible involvement of immune cells and mediators
in the helminth-induced immunomodulation on T helper subsets.
Substances contained in the bodies of helminths or their excretory
secretory (ES) products are recognized by innate immune cells
via PAMPs receptors like TLRs. Thereafter, various changes occur
in the immune cells, for example, down-modulation of IL-
12/23p40 expression (DC), alternative activation (macrophages),
proliferation and/or IL-10 production (Treg, Tr1, and B cells),
and IL-4 production (basophils). We can observe suppression of
immune disorders with down-regulation of pathogenic T helper
subsets (Th1, Th17, and allergic Th2) as consequence of mixed
eﬀects of such immunological changes.
described, we examined eﬀects of S. mansoni infection on
CIA in mice. In humans, schistosomiasis has been reported
as “arthritogenic” rather than anti-arthritic [79, 80]. In our
experiments, however, S. mansoni infection lowered arthritis
scores and numbers of arthritic paws [47]. Histopathological
examination revealed that cell inﬁltration and bone/cartilage
destruction were diminished in the infected mice.
In CIA and RA, the pathogenic roles of IL-1 and
IL-6 are well established [82–84]. We observed that the
marked augmentation of IL-1β and IL-6 gene expression in
the paws was almost completely abrogated by S. mansoni
infection [47]. It was especially noteworthy that receptor
activator of NFκB ligand (RANKL) gene expression in the
inﬂamedpawswasalsoabrogatedbyS.mansoniinfection.As
RANKLexpression is inducedbyproinﬂammatorycytokines
including IL-17, TNF-α,a n dI L - 1 β [85] and essential to
osteoclast development followed by bone destruction [86–
88], this result suggests that schistosome infection has anti-
arthritic eﬀects preventing bone destruction. Interestingly,
we also found that intraperitoneally administered schisto-
some worm antigens (SWAP) or egg antigens (SEA) did not
aﬀect the progress of CIA (unpublished observation). In the
antigen-administered mice, levels of IL-10, TNFα, and IL-17
producedbysplenocyteswerecomparabletothoseinantigen
nonadministered control mice. Thus, regarding schistosome,
there is a considerable diﬀerence in immunomodulating
eﬀects between infection and antigen administration.Journal of Biomedicine and Biotechnology 5
5.FutureClinicalApplicationsof Helminths
andTheir Products
As described above, our experiments with schistosome
showed that anti-arthritic eﬀects were observed only in
the viable worm infected mice. Likewise, Hunter et al.
showed that anticolitic eﬀects of Hymenolepis diminuta were
dependent on a viable infection [41], and surprisingly,
Melon et al. showed that therapeutic eﬃcacy of the viable
tapeworm was superior to dexamethazone treatment [44,i n
this issue]. Because of these observations in experimental
models, attenuated or non/lowly-pathogenic helminths are
worth testing directly for therapeutic eﬀects. In fact, porcine
whipworm (Trichuris suis)e g g sa n dNecator americanus
infective larvae have been clinically tested for the treatment
ofchronicinﬂammatoryorallergicdiseases.ReddyandFried
[89] summarized the recent progress in clinical trials using
these two intestinal nematodes. Summers et al. reported
that the administration of T. suis eggs eﬀectively ameliorated
both UC and CD [90, 91] without adverse eﬀects. N.
americanus is also under clinical trials for asthmatic patients
[92].Thiswormisconsideredsuperiortoporcinewhipworm
in that repeated administration is not needed.
Although it is not permissible to directly apply highly
pathogenic helminths (e.g., schistosome) to clinical use,
puriﬁed or synthetic immunomodulatory products from
such worms can be considered for clinical purposes. Various
immunomodulatory molecules (carbohydrates, proteins,
and lipids) have been identiﬁed; for example, Lacto-N-
fucopentaose III (LNFP III) contained in schsitosome eggs is
an oligosaccalide as the molecule aﬀecting B cells (especially
B-1 cells) to induce IL-10 production [93]. LNFP III was
also reported to alternatively activate macrophages [94].
A chemokine-binding protein (CBP) from schsitosome eggs
inhibited the recruitment of neutrophils [95] to inﬂam-
matory foci. Peroxiredoxin (Prx) is an antioxidant protein
found in various species including helminths [96, 97]. The
molecules from S. mansoni and F. hepatica alternatively
activate macrophages and are involved in the induction
of a Th2-type immune response [97]. The IL-4-inducing
principle of S. mansoni eggs (IPSE) is the molecule that
induces “primary” IL-4 production from basophils [98].
Regardinganti-arthriticeﬀects,aglycoproteinfromSpirome-
tra erinaceieuropaei was shown to suppress RANKL-induced
osteoclastogenesis, suggesting that there may be more anti-
arthritic substances in various helminths [99].
6. Concluding Remarks
Helminth-based immunotherapy for immnunological dis-
orders is still in its infancy. It should be pointed out that
helminths do not always suppress autoimmune/allergic dis-
orders. There are epidemiological and experimental reports
that helminths exacerbate such disorders [10]. Apart from
Th2-biasing abilities of helminths, allergens contained in
the worms may partially explain the mechanisms of exac-
erbation. Ascaris extract has cross-reactivity with domestic
mite allergens [100]. Moreover, Ascaris was shown to have
an allergenic component (APAS-3) [38]. Mice infected
with Toxocara canis showed exacerbation of allergic airway
inﬂammation [55] whereas hookworm (Nippostrongylus
brasiliensis)infection persistently reduced airway responsive-
ness in mice [101], suggesting that there are considerable
diﬀerences of outcomes even among lung-migratory nema-
todes. Thus, careful selection of “therapeutic” helminths
and their target diseases is essential. Further studies on
the mechanisms of immunomodulation are necessary for
future human applications. The roles of Th1/Th17/Treg-
related regulatory cytokines (IL-25, IL-27, IL-35, etc.) in
the helminth-induced suppression of allergy/autoimmunity
have not been suﬃciently studied. It is well known that
the roles of cytokines in human Th17 diﬀerentiation are
very diﬀerent from those in mice [12, 102]. For clinical
applications in the future, we should ascertain changes in
Th17-related cytokine patterns not only in animal models
but also in patients with helminthiasis. It was reported that
concurrent ﬁlarial infection suppressed both Th1 and Th17
responses to Mycobacterium tuberculosis [103]. This implies
that helminths have down-regulating activity of both Th1
a n dT h 1 7i nh u m a n sa sw e l la si nm i c e .
In human RA, the relative importance of Th1 and Th17
is still unclear, and therefore, suppression of both T helper
responses is recommended [102]. Thus, at present we can
conclude that regulatory eﬀects on both Th1 and Th17 are
promising characteristics of helminths as anti-inﬂammatory
agents.However,theinterpretationofexperimentalresultsof
helminth-inducedimmunomodulationmaychangedepend-
ing on changes in basic immunological knowledge. Indeed,
it was recently reported that T-bet expression was more
important in the pathogenesis of EAE than the Th1/Th17
balance [104]. Therefore, further studies of helminth-
induced amelioration of immune disorders should strictly
follow the studies of the diseases’ pathogenesis.
As noted, in experimental animal studies, viable
helminth infections seem to be superior to the administra-
tion of worm antigens or killed worms in the therapeutic
eﬀects. This might be due to that viable helminths can regu-
late secretion of immunomodulatory molecules in the most
appropriateconditionsfortheirsurvival.Takentogetherwith
successful treatment of UC and CD with viable porcine
whipworms [90, 91], the optimal attenuation of human
parasites by gene manipulation may be useful for the clinical
application of parasitic helminths in the future.
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